Kolon Life Science Inc

Chart & Performance

D1W1MN

P/E

19.34

P/S

2.30

EPS

2,176.78

Div Yield, %

—

Shrs. gr., 5y

2.51%

Rev. gr., 5y

10.06%

Revenues

208.98b

+29.49%

Net income

24.84b

CFO

10.21b

Dividend

Dec 28, 2016300 KRW/sh

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Kolon Life Science Inc. is primarily engaged in the creation and distribution of pharmaceutical products and environmental materials. The company's operations are organized into two distinct units: Chemical and Bio. Its Chemical division manages both pharmaceutical activities and the development of specialty chemicals. In contrast, the Bio business unit is focused on providing contract development and manufacturing services for biopharmaceuticals. The enterprise was founded on April 21, 2000, and its corporate headquarters are situated in Seoul, South Korea.

URL

https://www.kolonls.co.kr/

IPO date

Apr 07, 2009

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title KRW in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY
Title KRW in thousands, except ratios and share amounts	2025‑12	2024‑12	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT